FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thérèse Di Paolo

Research Profile

Living Beings

Procedures

Anatomy

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Laurent Grégoire; Vincent A Jourdain; Arthur Roach; Matthew Townsend; Thérèse Di Paolo
Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys.
S Al Sweidi; Marc Morissette; C Rouillard; Thérèse Di Paolo
Estrogen receptors and lesion-induced response of striatal dopamine receptors.
Nicolas Morin; Marc Morissette; Sandrine Desrayaud; Fabrizio Gasparini; Baltazar Gomez-Mancilla; Laurent Grégoire; Thérèse Di Paolo
MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thérèse Di Paolo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Laurent Grégoire; Vincent A Jourdain; Arthur Roach; Matthew Townsend; Thérèse Di Paolo
Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys.
Parkinsonism & related disorders 2013;19(5):508-14.
2013: S Al Sweidi; Marc Morissette; C Rouillard; Thérèse Di Paolo
Estrogen receptors and lesion-induced response of striatal dopamine receptors.
Neuroscience 2013;236():99-109.
2013: Nicolas Morin; Marc Morissette; Sandrine Desrayaud; Fabrizio Gasparini; Baltazar Gomez-Mancilla; Laurent Grégoire; Thérèse Di Paolo
MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
Neuropharmacology 2013;66():355-64.
2013: Mélanie Bourque; Mélissa Côté; Marc Morissette; Denis Soulet; Thérèse Di Paolo
Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease.
Neurobiology of aging 2013;34(3):887-901.
2013: Vincent A Jourdain; Nicolas Morin; Marc Morissette; Martin Parent; Laurent Grégoire; Thérèse Di Paolo
Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy.
Journal of neurosurgery 2013;118(1):180-91.
2012: Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways.
Neuropharmacology 2012;62(7):2363-72.
2012: Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
Frontiers in neuroendocrinology 2012;33(2):169-78.
2012: Sarah Paris-Robidas; Mireille Pilote; Alex Rajput; Ali H Rajput; Marion Sintes; Cyntia Tremblay; Milène Vandal; Mélanie Bousquet; Elodie Brochu; Thérèse Di Paolo; Vincent Emond; Frederic Calon
Defective dentate nucleus GABA receptors in essential tremor.
Brain : a journal of neurology 2012;135(Pt 1):105-16.
2011: Sara Al-Sweidi; Mélanie Bourque; Marc Morissette; Thérèse Di Paolo
Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
Neuropharmacology 2011;61(4):583-91.
2011: Mélanie Bourque; Dean E Dluzen; Bin Liu; Thérèse Di Paolo
Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.
Psychoneuroendocrinology 2011;36(7):955-69.
2011: Bazoumana Ouattara; Alex Rajput; Ali H Rajput; Ivo Vranesic; Fabrizio Gasparini; Baltazar Gomez-Mancilla; Laurent Grégoire; Oleh Hornykiewicz; Donald R Johns; Marc Morissette; Graeme Bilbe; Thérèse Di Paolo
Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.
Neurobiology of aging 2011;32(7):1286-95.
2011: Daniela Berg; Katy Cooke; Iiona Csoti; Thérèse Di Paolo; Karla Eggert; Fabrizio Gasparini; Jana Godau; Sam Hariry; Heiko Huber; Donald Johns; Monica Morelli-Canelo; Vincent Ries; Christine Schneider; Maria Stamelou; Alexander Storch; Claudia Trenkwalder; Marc Vandemeulebroecke; Martin Wolz; Walid Abi-Saab; Baltazar Gomez-Mancilla
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials.
Movement disorders : official journal of the Movement Disorder Society 2011;26(7):1243-50.
2011: Laurent Grégoire; Nicolas Morin; Bazoumana Ouattara; Fabrizio Gasparini; Graeme Bilbe; Donald Johns; Ivo Vranesic; Srikumar Sahasranaman; Baltazar Gomez-Mancilla; Thérèse Di Paolo
The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys.
Parkinsonism & related disorders 2011;17(4):270-6.
2011: Maria Gabriela Sánchez; erika estrada-camarena; Nancy Bélanger; Marc Morissette; Thérèse Di Paolo
Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy.
Neuropharmacology 2011;60(4):642-52.
2011: Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Male/Female differences in neuroprotection and neuromodulation of brain dopamine.
Frontiers in endocrinology 2011;2():35.
2010: B Ouattara; D Hoyer; L Grégoire; Marc Morissette; F Gasparini; Baltazar Gomez-Mancilla; Thérèse Di Paolo
Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias.
Neuroscience 2010;167(4):1160-7.
2010: Maria Gabriela Sánchez; Mélanie Bourque; Marc Morissette; Thérèse Di Paolo
Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders.
CNS neuroscience & therapeutics 2010;16(3):e43-71.
2010: Nicolas Morin; Laurent Grégoire; Baltazar Gomez-Mancilla; Fabrizio Gasparini; Thérèse Di Paolo
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys.
Neuropharmacology 2010;58(7):981-6.
2010: Bazoumana Ouattara; Fabrizio Gasparini; Marc Morissette; Laurent Grégoire; Pershia Samadi; Baltazar Gomez-Mancilla; Thérèse Di Paolo
Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
Journal of neurochemistry 2010;113(3):715-24.
2010: Marc Morissette; Pershia Samadi; Abdallah Hadj Tahar; Nancy Bélanger; Thérèse Di Paolo
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(3):446-54.
2010: Pershia Samadi; Marc Morissette; Daniel Lévesque; Thérèse Di Paolo
BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.
Movement disorders : official journal of the Movement Disorder Society 2010;25(1):116-21.
2010: Mohamed Khalil Tamim; Pershia Samadi; Marc Morissette; Laurent Grégoire; Bazoumana Ouattara; Daniel Lévesque; Claude Rouillard; Thérèse Di Paolo
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Neuropharmacology 2010;58(1):286-96.
2009: Souha Mahmoudi; Pershia Samadi; François Gilbert; Bazoumana Ouattara; Marc Morissette; Laurent Grégoire; Claude Rouillard; Thérèse Di Paolo; Daniel Lévesque
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid.
Neurobiology of disease 2009;36(1):213-22.
2009: Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Neuroprotective actions of sex steroids in Parkinson's disease.
Frontiers in neuroendocrinology 2009;30(2):142-57.
2009: Laurent Grégoire; Pershia Samadi; Julie Graham; Paul J Bédard; Gerd D Bartoszyk; Thérèse Di Paolo
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
Parkinsonism & related disorders 2009;15(6):445-52.
2009: Bazoumana Ouattara; Samah Belkhir; Marc Morissette; Mehdi Dridi; Pershia Samadi; Laurent Grégoire; Leonard T Meltzer; Thérèse Di Paolo
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.
Journal of molecular neuroscience : MN 2009;38(2):128-42.
2009: Marc Morissette; Thérèse Di Paolo
Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys.
Journal of neuroscience research 2009;87(7):1634-44.
2009: Pershia Samadi; Alex Rajput; Frederic Calon; Laurent Grégoire; Oleh Hornykiewicz; Ali H Rajput; Thérèse Di Paolo
Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
Journal of neuropathology and experimental neurology 2009;68(4):374-82.
2008: Marc Morissette; Sara Al Sweidi; Sophie Callier; Thérèse Di Paolo
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
Molecular and cellular endocrinology 2008;290(1-2):60-9.
2008: Marc Morissette; Maryvonne Le Saux; Thérèse Di Paolo
Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors.
Journal of neuroendocrinology 2008;20(8):1006-14.
2008: Pershia Samadi; Laurent Grégoire; Marc Morissette; Frederic Calon; Abdallah Hadj Tahar; Mehdi Dridi; Nancy Belanger; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Neurobiology of aging 2008;29(7):1040-51.
2008: Pershia Samadi; Laurent Grégoire; Marc Morissette; Frederic Calon; Abdallah Hadj Tahar; Nancy Bélanger; Mehdi Dridi; Paul J Bédard; Thérèse Di Paolo
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
Neuropharmacology 2008;54(2):258-68.
2008: Pershia Samadi; Marc Morissette; Frederic Calon; Abdallah Hadj Tahar; Mehdi Dridi; Nancy Belanger; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys.
Synapse (New York, N.Y.) 2008;62(2):101-9.
2008: Marc Morissette; Maryvonne Le Saux; Myreille D'Astous; S Jourdain; S Al Sweidi; N Morin; erika estrada-camarena; Pablo Mendez; Luis M Garcia-Segura; Thérèse Di Paolo
Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.
The Journal of steroid biochemistry and molecular biology 2008;108(3-5):327-38.
2008: Laurent Grégoire; Arash Rassoulpour; Paolo Guidetti; Pershia Samadi; Paul J Bédard; Emanuela Izzo; Robert Schwarcz; Thérèse Di Paolo
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Behavioural brain research 2008;186(2):161-7.
2007: Mélanie Bourque; Bin Liu; Dean E Dluzen; Thérèse Di Paolo
Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
Biochemical pharmacology 2007;74(9):1413-23.
2007: Marc Morissette; Sandra Jourdain; Sara Al Sweidi; Frank S Menniti; Andres D Ramirez; Thérèse Di Paolo
Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
Neuropharmacology 2007;52(7):1509-20.
2007: Pershia Samadi; Claude Rouillard; Paul J Bédard; Thérèse Di Paolo
Functional neurochemistry of the basal ganglia.
Handbook of clinical neurology 2007;83():19-66.
2006: Nancy Bélanger; Laurent Grégoire; Paul J Bédard; Thérèse Di Paolo
DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys.
Neurobiology of aging 2006;27(11):1684-93.
2006: Maryvonne Le Saux; erika estrada-camarena; Thérèse Di Paolo
Selective estrogen receptor-alpha but not -beta agonist treatment modulates brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Journal of neuroscience research 2006;84(5):1076-84.
2006: François Gilbert; Marc Morissette; Michel St-Hilaire; Brigitte Paquet; Claude Rouillard; Thérèse Di Paolo; Daniel Lévesque
Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover.
Biological psychiatry 2006;60(6):538-47.
2006: Marc Morissette; Mehdi Dridi; Frederic Calon; Abdallah Hadj Tahar; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Synapse (New York, N.Y.) 2006;60(3):239-50.
2006: Carl Julien; Line Berthiaume; Abdallah Hadj Tahar; Ali H Rajput; Paul J Bédard; Thérèse Di Paolo; Pierre Julien; Frederic Calon
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Neurochemistry international 2006;48(5):404-14.
2006: Myreille D'Astous; Pablo Mendez; Marc Morissette; Luis M Garcia-Segura; Thérèse Di Paolo
Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Molecular pharmacology 2006;69(4):1492-8.
2006: Maryvonne Le Saux; Marc Morissette; Thérèse Di Paolo
ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens.
Neuropharmacology 2006;50(4):451-7.
2006: Pershia Samadi; Laurent Grégoire; Claude Rouillard; Paul J Bédard; Thérèse Di Paolo; Daniel Lévesque
Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Annals of neurology 2006;59(2):282-8.
2006: Maryvonne Le Saux; Thérèse Di Paolo
Influence of oestrogenic compounds on monoamine transporters in rat striatum.
Journal of neuroendocrinology 2006;18(1):25-32.
2006: Marc Morissette; Mehdi Dridi; Frederic Calon; Abdallah Hadj Tahar; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):9-17.
2005: S Jourdain; Marc Morissette; N Morin; Thérèse Di Paolo
Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Journal of neuroendocrinology 2005;17(8):509-17.
2005: Pershia Samadi; Laurent Grégoire; Abdallah Hadj Tahar; Thérèse Di Paolo; Claude Rouillard; Paul J Bédard
Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.
Neuropharmacology 2005;49(2):165-73.
2005: Louis-Jean Bordeleau; Laimonis Gailis; Dominique Fournier; Marc Morissette; Thérèse Di Paolo; Pascal Daleau
Cut-off phenomenon in the protective effect of alcohols against lysophosphatidylcholine-induced calcium overload.
Pflügers Archiv : European journal of physiology 2005;450(5):292-7.
2005: Myreille D'Astous; Marc Morissette; Sophie Callier; Thérèse Di Paolo
Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.
Journal of neuroscience research 2005;80(1):138-44.
2005: Maryvonne Le Saux; Thérèse Di Paolo
Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens.
Psychoneuroendocrinology 2005;30(3):251-60.
2005: Maryvonne Le Saux; Thérèse Di Paolo
Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Journal of psychiatry & neuroscience : JPN 2005;30(2):110-7.
2005: Myreille D'Astous; Katherine R Mickley; Dean E Dluzen; Thérèse Di Paolo
Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.
Neuroendocrinology 2005;82(2):111-20.
2004: Myreille D'Astous; Marc Morissette; Thérèse Di Paolo
Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.
Neuropharmacology 2004;47(8):1180-8.
2004: Pierre J Blanchet; Frederic Calon; Marc Morissette; Abdallah Hadj Tahar; Nancy Bélanger; Pershia Samadi; Richard Grondin; Laurent Grégoire; Leonard T Meltzer; Thérèse Di Paolo; Paul J Bédard
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
Parkinsonism & related disorders 2004;10(5):297-304.
2004: Ali H Rajput; Mark E Fenton; Thérèse Di Paolo; Harold Sitte; Christian Pifl; Oleh Hornykiewicz
Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off.
Parkinsonism & related disorders 2004;10(4):221-6.
2004: Frederic Calon; Mehdi Dridi; Oleh Hornykiewicz; Paul J Bédard; Ali H Rajput; Thérèse Di Paolo
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Brain : a journal of neurology 2004;127(Pt 5):1075-84.
2004: Myreille D'Astous; Tapasdip M Gajjar; Dean E Dluzen; Thérèse Di Paolo
Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
Neuroendocrinology 2004;79(6):296-304.
2003: Frederic Calon; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Neurobiology of disease 2003;14(3):404-16.
2003: Nancy Bélanger; Laurent Grégoire; Paul J Bédard; Thérèse Di Paolo
Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Endocrine 2003;21(1):97-101.
2003: Michelle Landry; Thérèse Di Paolo
Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
Brain research. Molecular brain research 2003;112(1-2):82-9.
2003: Frederic Calon; Marc Morissette; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):241-53.
2003: Abdallah Hadj Tahar; Richard Grondin; Laurent Grégoire; Frederic Calon; Thérèse Di Paolo; Paul J Bédard
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Advances in neurology 2003;91():51-64.
2003: Myreille D'Astous; Marc Morissette; Bastien Tanguay; Sophie Callier; Thérèse Di Paolo
Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
Synapse (New York, N.Y.) 2003;47(1):10-4.
2002: Christian Vaillancourt; Michel Cyr; Joseph Rochford; Patricia Boksa; Thérèse Di Paolo
Effects of ovariectomy and estradiol on acoustic startle responses in rats.
Pharmacology, biochemistry, and behavior 2002;74(1):103-9.
2002: Michelle Landry; Daniel Lévesque; Thérèse Di Paolo
Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.
Neuroendocrinology 2002;76(4):214-22.
2002: Frederic Calon; Thérèse Di Paolo
Levodopa response motor complications--GABA receptors and preproenkephalin expression in human brain.
Parkinsonism & related disorders 2002;8(6):449-54.
2002: A Ekue; J-F Boulanger; Marc Morissette; Thérèse Di Paolo
Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice.
Journal of neuroendocrinology 2002;14(9):731-6.
2002: Frederic Calon; Sam Birdi; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Journal of neuropathology and experimental neurology 2002;61(2):186-96.
2002: Sophie Callier; Maryvonne Le Saux; Anne-Marie Lhiaubet; Thérèse Di Paolo; William Rostène; Didier Pelaprat
Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
Journal of neurochemistry 2002;80(2):307-16.
2002: Frederic Calon; Marc Morissette; Othman Ghribi; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):127-38.
2002: Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.
Journal of psychiatry & neuroscience : JPN 2002;27(1):12-27.
2001: P K Tekumalla; Frederic Calon; Zia Rahman; Sam Birdi; Ali H Rajput; Oleh Hornykiewicz; Thérèse Di Paolo; Paul J Bédard; Eric J Nestler
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
Biological psychiatry 2001;50(10):813-6.
2001: M Cyr; Othman Ghribi; C Thibault; Marc Morissette; M Landry; Thérèse Di Paolo
Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors.
Brain research. Brain research reviews 2001;37(1-3):153-61.
2001: M Cyr; C Thibault; Marc Morissette; M Landry; Thérèse Di Paolo
Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(2):242-57.
2001: Sophie Callier; Marc Morissette; M Grandbois; D Pélaprat; Thérèse Di Paolo
Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
Synapse (New York, N.Y.) 2001;41(2):131-8.
2001: Frederic Calon; N Lavertu; A M Lemieux; Marc Morissette; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Synapse (New York, N.Y.) 2001;40(3):225-34.
2001: M Cyr; Marc Morissette; M Landry; Thérèse Di Paolo
Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.
Neuroreport 2001;12(3):535-9.
2001: Pierre J Blanchet; Frederic Calon; Marc Morissette; Marlyne Goulet; Richard Grondin; Daniel Lévesque; Paul J Bédard; Thérèse Di Paolo
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
Advances in neurology 2001;86():337-44.
2001: M Cyr; Marc Morissette; Nicholas Barden; S Beaulieu; Joseph Rochford; Thérèse Di Paolo
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Neuroscience 2001;102(1):151-8.
2001: M Cyr; C Charbonneau; Marc Morissette; Joseph Rochford; Nicholas Barden; Thérèse Di Paolo
Central 5-hydroxytryptamine-2A receptor expression in transgenic mice bearing a glucocorticoid receptor antisense.
Neuroendocrinology 2001;73(1):37-45.
2000: Frederic Calon; Abdallah Hadj Tahar; Pierre J Blanchet; Marc Morissette; Richard Grondin; Marlyne Goulet; JP Doucet; George S Robertson; E Nestler; Thérèse Di Paolo; Paul J Bédard
Dopamine-receptor stimulation: biobehavioral and biochemical consequences.
Trends in neurosciences 2000;23(10 Suppl):S92-100.
2000: Sophie Callier; Marc Morissette; M Grandbois; Thérèse Di Paolo
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
Synapse (New York, N.Y.) 2000;37(4):245-51.
2000: M Cyr; Frederic Calon; Marc Morissette; M Grandbois; Thérèse Di Paolo; Sophie Callier
Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS.
Current pharmaceutical design 2000;6(12):1287-312.
2000: M Cyr; M Landry; Thérèse Di Paolo
Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(1):69-78.
2000: Marlyne Goulet; Richard Grondin; Marc Morissette; S Maltais; P Falardeau; Paul J Bédard; Thérèse Di Paolo
Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(4):607-17.
2000: M Cyr; Othman Ghribi; Thérèse Di Paolo
Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain.
Journal of neuroendocrinology 2000;12(5):445-52.
2000: Frederic Calon; Marc Morissette; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
Experimental neurology 2000;163(1):191-9.
2000: Frederic Calon; Richard Grondin; Marc Morissette; Marlyne Goulet; Pierre J Blanchet; Thérèse Di Paolo; Paul J Bédard
Molecular basis of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S70-8.
2000: M Grandbois; Marc Morissette; Sophie Callier; Thérèse Di Paolo
Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice.
Neuroreport 2000;11(2):343-6.
1999: Marc Morissette; A Dicko; Michel Pézolet; Sophie Callier; Thérèse Di Paolo
Effect of dehydroepiandrosterone and its sulfate and fatty acid ester derivatives on rat brain membranes.
Steroids 1999;64(11):796-803.
1999: Richard Grondin; Marlyne Goulet; Marc Morissette; Paul J Bédard; Thérèse Di Paolo
Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
European journal of pharmacology 1999;378(3):259-63.
1999: A Dicko; Marc Morissette; S Ben Ameur; Michel Pézolet; Thérèse Di Paolo
Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy.
Brain research bulletin 1999;49(6):401-5.
1999: Frederic Calon; Marc Morissette; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content.
Neurochemistry international 1999;35(1):81-91.
1999: Marlyne Goulet; Marc Morissette; Richard Grondin; P Falardeau; Paul J Bédard; W Rostène; Thérèse Di Paolo
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Synapse (New York, N.Y.) 1999;32(3):153-64.
1999: Marc Morissette; Richard Grondin; Marlyne Goulet; Paul J Bédard; Thérèse Di Paolo
Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
Journal of neurochemistry 1999;72(2):682-92.
1998: Marc Morissette; Marlyne Goulet; Richard Grondin; P Blanchet; Paul J Bédard; Thérèse Di Paolo; Daniel Lévesque
Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
The European journal of neuroscience 1998;10(8):2565-73.
1998: A Dicko; Thérèse Di Paolo; Michel Pézolet
Interaction of dehydroepiandrosterone with phospholipid membranes: an infrared spectroscopy investigation.
Biochimica et biophysica acta 1998;1368(2):321-8.
1997: Marc Morissette; Marlyne Goulet; J J Soghomonian; Pierre J Blanchet; Frederic Calon; Paul J Bédard; Thérèse Di Paolo
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
Brain research. Molecular brain research 1997;49(1-2):55-62.
1997: M Carli; Marc Morissette; C Hébert; Thérèse Di Paolo; Tomás A Reader
Effects of a chronic lithium treatment on central dopamine neurotransporters.
Biochemical pharmacology 1997;54(3):391-7.
1997: Marlyne Goulet; Marc Morissette; Frederic Calon; Pierre J Blanchet; P Falardeau; Paul J Bédard; Thérèse Di Paolo
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.
Neuroscience 1997;79(2):497-507.
1997: R Bossé; R Rivest; Thérèse Di Paolo
Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain.
Brain research. Molecular brain research 1997;46(1-2):343-6.
1996: Marc Morissette; Marlyne Goulet; Frederic Calon; P Falardeau; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Molecular pharmacology 1996;50(5):1073-9.
1996: Richard Grondin; Marlyne Goulet; Thérèse Di Paolo; Paul J Bédard
Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.
Brain research 1996;735(2):298-306.
1996: JJ Soghomonian; S Pedneault; Pierre J Blanchet; Marlyne Goulet; Thérèse Di Paolo; Paul J Bédard
L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys.
Brain research. Molecular brain research 1996;39(1-2):237-40.
1996: Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys.
Brain research 1996;719(1-2):129-37.
1995: R Rivest; P Falardeau; Thérèse Di Paolo
Brain dopamine transporter: gender differences and effect of chronic haloperidol.
Brain research 1995;692(1-2):269-72.
1995: C Gagnon; B Gomez-Mancilla; R Markstein; Paul J Bédard; Thérèse Di Paolo
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(4):667-76.
1995: Frederic Calon; Marlyne Goulet; Pierre J Blanchet; J C Martel; M F Piercey; Paul J Bédard; Thérèse Di Paolo
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Brain research 1995;680(1-2):43-52.
1995: M Petitclerc; Paul J Bédard; Thérèse Di Paolo
Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(3):491-7.
1995: Pierre J Blanchet; Frederic Calon; J C Martel; Paul J Bédard; Thérèse Di Paolo; R R Walters; M F Piercey
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.
The Journal of pharmacology and experimental therapeutics 1995;272(2):854-9.
1995: Pierre J Blanchet; B Gomez-Mancilla; Thérèse Di Paolo; Paul J Bédard
Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?
Fundamental & clinical pharmacology 1995;9(5):434-42.
1994: Thérèse Di Paolo
Modulation of brain dopamine transmission by sex steroids.
Reviews in the neurosciences 1994;5(1):27-41.
1993: C Gagnon; B Gomez-Mancilla; Paul J Bédard; Thérèse Di Paolo
Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.
Neuroscience letters 1993;163(1):31-5.
1993: L Rioux; C Gagnon; D P Gaudin; Thérèse Di Paolo; Paul J Bédard
A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors.
Neuroscience 1993;56(1):45-51.
1993: Marc Morissette; Thérèse Di Paolo
Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.
Journal of neurochemistry 1993;60(5):1876-83.
1993: B Gomez-Mancilla; R Boucher; C Gagnon; Thérèse Di Paolo; R Markstein; Paul J Bédard
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):144-50.
1993: C Gagnon; Paul J Bédard; Thérèse Di Paolo
Grafts in the treatment of Parkinson's disease: animal models.
Reviews in the neurosciences 1993;4(1):17-40.
1992: Marc Morissette; Daniel Lévesque; Thérèse Di Paolo
Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
Molecular pharmacology 1992;42(3):480-8.
1992: M Morissette; L M Garcia-Segura; A Bélanger; Thérèse Di Paolo
Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle.
Neuroscience 1992;49(4):893-902.
1992: D Biron; C Dauphin; Thérèse Di Paolo
Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors.
Neuroendocrinology 1992;55(4):468-76.
1991: C Gagnon; Paul J Bédard; L Rioux; D Gaudin; M G Martinoli; G Pelletier; Thérèse Di Paolo
Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Brain research 1991;558(2):251-63.
1991: Daniel Lévesque; Thérèse Di Paolo
Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
Molecular pharmacology 1991;39(5):659-65.
1991: L Rioux; D P Gaudin; C Gagnon; Thérèse Di Paolo; Paul J Bédard
Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
Neuroscience 1991;44(1):75-83.
1990: Marc Morissette; Daniel Lévesque; A Bélanger; Thérèse Di Paolo
A physiological dose of estradiol with progesterone affects striatum biogenic amines.
Canadian journal of physiology and pharmacology 1990;68(12):1520-6.
1990: Marc Morissette; D Biron; Thérèse Di Paolo
Effect of estradiol and progesterone on rat striatal dopamine uptake sites.
Brain research bulletin 1990;25(3):419-22.
1990: Claude Rouillard; Paul J Bédard; Thérèse Di Paolo
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
European journal of pharmacology 1990;185(2-3):209-15.
1990: C Gagnon; Paul J Bédard; Thérèse Di Paolo
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
European journal of pharmacology 1990;178(1):115-20.
1990: Daniel Lévesque; Thérèse Di Paolo
Effect of the rat estrous cycle at ovariectomy on striatal D-1 dopamine receptors.
Brain research bulletin 1990;24(2):281-4.
1989: Thérèse Di Paolo; Claude Rouillard; Marc Morissette; Daniel Lévesque; Paul J Bédard
Endocrine and neurochemical actions of cocaine.
Canadian journal of physiology and pharmacology 1989;67(9):1177-81.
1989: Daniel Lévesque; S Gagnon; Thérèse Di Paolo
Striatal D1 dopamine receptor density fluctuates during the rat estrous cycle.
Neuroscience letters 1989;98(3):345-50.
1989: Thérèse Di Paolo; F Bédard; Paul J Bédard
Influence of gonadal steroids on human and monkey cerebrospinal fluid homovanillic acid concentrations.
Clinical neuropharmacology 1989;12(1):60-6.
1989: Daniel Lévesque; Thérèse Di Paolo
Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors.
Life sciences 1989;45(19):1813-20.
1988: Claude Rouillard; P Bédard; P Falardeau; Thérèse Di Paolo
Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
European journal of pharmacology 1988;157(2-3):125-33.
1988: Thérèse Di Paolo; M A Bernier
Estradiol and guanine nucleotide modulation of dopamine receptor agonist and antagonist binding sites in 7315a pituitary tumors.
Biochemical pharmacology 1988;37(12):2373-9.
1988: P Falardeau; S Bouchard; Paul J Bédard; R Boucher; Thérèse Di Paolo
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
European journal of pharmacology 1988;150(1-2):59-66.
1988: Daniel Lévesque; Thérèse Di Paolo
Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol.
Neuroscience letters 1988;88(1):113-8.
1988: P Falardeau; Paul J Bédard; Thérèse Di Paolo
Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.
Neuroscience letters 1988;86(2):225-9.
1988: Thérèse Di Paolo; Daniel Lévesque
Sodium and guanine nucleotide regulation of dopamine receptor agonist and antagonist binding sites in MtTW15 pituitary tumors.
Canadian journal of physiology and pharmacology 1988;66(3):246-9.
1988: Thérèse Di Paolo; P Falardeau; Marc Morissette
Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle.
Life sciences 1988;43(8):665-72.
1985: Thérèse Di Paolo; Claude Rouillard; P Bédard
17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain.
European journal of pharmacology 1985;117(2):197-203.
1984: P Deshaies; P Bédard; P Falardeau; Thérèse Di Paolo
Behavioral and biochemical evidence of apomorphine-induced supersensitivity of the striatal dopamine receptors.
Neuropharmacology 1984;23(10):1219-22.